Indaptus Therapeutics

Cash burn rate (est.)	Burn method: Change in cash		Burn method: Operating income		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	11.14 mm	11.14 mm	11.14 mm	11.14 mm	11.14 mm	11.14 mm
Cash burn (monthly)	1.18 mm	(no burn)	1.40 mm	1.20 mm	1.44 mm	889.58 k
Cash used (since last report)	52.81 mm	n/a	62.86 mm	53.79 mm	64.38 mm	39.85 mm
Cash remaining	-41.67 mm	n/a	-51.72 mm	-42.66 mm	-53.24 mm	-28.72 mm
Runway (months of cash)	-35.4	n/a	-36.9	-35.5	-37.1	-32.3

Beta Read what these cash burn values mean

Financial data from company earnings reports.

Institutional ownership, Q3 2021

Indaptus Therapeutics institutional ownership history Ownership history

4.4% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	2	13	-84.6%
Opened positions	0	2	EXIT
Closed positions	11	8	+37.5%
Increased positions	0	1	EXIT
Reduced positions	0	3	EXIT

13F shares	Current	Prev Q	Change
Total value	1.25 mm	3.55 mm	-64.9%
Total shares	360.93 k	1.03 mm	-64.8%
Total puts	0.00	0.00
Total calls	0.00	0.00
Total put/call ratio	–	–	–

Largest owners	Shares	Value	Change
Intracoastal Capital	265.93 k	$917.00 k	0.0%
CVI Investments	95.00 k	$328.00 k	0.0%

Largest transactions	Bought/sold	Change
AdvisorShares Investments	-443.01 k	EXIT
Meitav Dash Investments	-120.99 k	EXIT
MS Morgan Stanley	-34.82 k	EXIT
Gsa Capital Partners	-33.29 k	EXIT
Squarepoint Ops	-19.20 k	EXIT
Citadel Advisors	-12.36 k	EXIT
WFC Wells Fargo & Company	-253.00	EXIT
Advisor	-250.00	EXIT
Cutler	-125.00	EXIT
Steward Partners Investment Advisory	-110.00	EXIT

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.